The drug maker announced that its wholly owned subsidiary, Eugia Pharma Specialties, received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Leuprolide Acetate injection, 14 mg/2.8 mL MDV (Kit).
Noida Toll Bridge Company Ltd, AGI Infra Ltd, New Delhi Television Ltd and Chemcrux Enterprises Ltd are among the other gainers in the BSEs B group today, 07 June 2022.
The Construction period is 730 days from the date of commencement of the project.
The key equity indices pared some losses in early afternoon trade. The Nifty traded above the 16,400 mark. Bank shares declined across the board. Mixed Asian cues and continuous selling by the FIIs dented sentiment. Investors were also cautious ahead of Reserve Bank of India (RBI)s policy announcement later this week. At 12:25 IST, the barometer index, the S&P BSE Sensex, was down 562.69 points […]
Australias central bank raised its key interest rate by half percentage points citing strong rise in inflation. The Reserve Bank of Australia decided to lift the cash rate target by 50 basis points to 0.85 percent from 0.35 percent. The central bank expects inflation to increase further, but then decline back towards the 2-3 percent range next year. Powered by Commodity Insights
Bharat Petroleum Corporation announced that the Govt. of India vide its letter dated 3 June 2022 has advised to call off the present EoI process for strategic disinvestment of BPCL and accordingly, all the activities in connection with the disinvestment including the data room are being discontinued. Powered by Capital Market – Live News
Sales decline 29.29% to Rs 0.99 crore
Business Wire India Akur8 and MS&AD Insurance Group are pleased to announce their new partnership to foster further innovation. With this deal, Akur8 continues to expand in Asia and beyond, hand-in-hand with a leading global insurer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220606005105/en/ Specifically developed for insurers, Akur8’s solution enhances model development processes by automating risk modeling, using Transparent […]
The Government of India (GoI) has announced the Sale (re-issue) of (i) 4.56% GS 2023 for a notified amount of Rs 4,000 crore (nominal) through price based auction using uniform price method; (ii) 7.10% GS 2029 for a notified amount of Rs 7,000 crore (nominal) through price based auction using uniform price method; (iii) 6.54% Government Security, 2032 for a notified amount of Rs 13,000 […]
With the addition of Tripura State with all its districts, Krsnaa has set foot across 15 states.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.